Skip to content
Menu

Coherus Oncology, Inc. CHRS

Full chart Compare
Set alert

Price alert · CHRS

All alert types
0.37 USD -0.02 (-4.47%)

Regular-session close

0.37 0.00 +0.59%

After hours · Nov 20, 6:09 PM ET

0.3628 Day range 0.4084
0.3628 52-week range 2.62
YTD
-73.96%
1 year
-66.38%

Revenue & Expenses

Revenue Profit Costs
Other Income$9.24MGross Profit$24.43MNet Loss$170.29MCost of Revenue$17.74MExpenses$203.97MSelling, General & Admin$99.00MResearch & Development$104.96MRevenue$42.17M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CHRS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
42.17M26.39M257.24M211.04M326.55M
28.36M17.66M98.25M140.96M268.96M
-181.13M-199.65M-203.20M-256.88M-263.86M
168.02M28.51M-237.89M-291.75M-287.10M
1.430.25-2.53-3.76-3.81
CHRS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.88M125.99M102.89M63.55M417.19M
258.34M448.53M629.60M480.85M679.33M
197.33M580.52M823.03M618.26M581.61M
37.05M268.21M478.70M476.10M415.53M
61.01M-131.99M-193.43M-137.42M97.73M
CHRS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-138.51M-20.44M-174.88M-241.12M-37.43M
375.09M230.32M144.64M-166.85M-138.41M
-273.70M-186.97M69.60M54.33M51.88M
-37.13M22.91M39.36M-353.65M-123.96M